Photo of Andrea F. Patenaude,  PhD

Andrea F. Patenaude, PhD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-3314
Fax: (617) 713-4466


andrea_patenaude@dfci.harvard.edu

Andrea F. Patenaude, PhD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Associate Professor, Psychiatry, Harvard Medical School
  • Director of Psycho-Oncology Research in the Divsion of Pediatric Oncology, Pediatric Oncology, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Research Abstract

For over 25 years I have been interested in the psychological adjustment of children and adults undergoing treatment for cancer. I particularly studied the impact of bone marrow transplantation on pediatric and adult patients and their families. Increasing survival of cancer patients has led to my strong interest in survivorship, resilience, and quality of life. More recently, my work has taken on the added focus of exploring the psychological impact of advances in cancer genetics. I have studied the psychosocial outcomes of women and men undergoing cancer genetic testing for p53 and BRCA1/2 and the experience of women undergoing prophylactic mastectomy for increased hereditary cancer risk.

Publications

Powered by Harvard Catalyst
  • Salley CG, Hewitt LL, Patenaude AF, Vasey MW, Yeates KO, Gerhardt CA, Vannatta K. Temperament and social behavior in pediatric brain tumor survivors and comparison peers. J Pediatr Psychol 2015. PubMed
  • Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer 2015. PubMed
  • Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF. Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. 2015. PubMed
  • Salley CG, Gerhardt CA, Fairclough DL, Patenaude AF, Kupst MJ, Barrera M, Vannatta K. Social self-perception among pediatric brain tumor survivors compared with peers. J Dev Behav Pediatr 2014; 35:427-34. PubMed
  • Mays D, DeMarco TA, Luta G, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Tercyak KP. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners. Health Psychol 2014. PubMed
  • Patenaude AF, Tung N, Ryan PD, Ellisen LW, Hewitt L, Schneider KA, Tercyak KP, Aldridge J, Garber JE. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry? 2013. PubMed
  • Ach E, Gerhardt CA, Barrera M, Kupst MJ, Meyer EA, Patenaude AF, Vannatta K. Family factors associated with academic achievement deficits in pediatric brain tumor survivors. 2013. PubMed
  • Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomarkers Prev 2013; 22:1260-6. PubMed
  • Farkas Patenaude A, DeMarco TA, Peshkin BN, Valdimarsdottir H, Garber JE, Schneider KA, Hewitt L, Hamilton J, Tercyak KP. Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns 2013. PubMed
  • Noll RB, Patel SK, Embry L, Hardy KK, Pelletier W, Annett RD, Patenaude A, Lown EA, Sands SA, Barakat LP, . Children's Oncology Group's 2013 blueprint for research: behavioral science. Pediatr Blood Cancer 2013; 60:1048-54. PubMed
  • Patenaude AF, Grootenhuis M, Noll R. Pediatric psycho-oncology comes of age: SIOP 2010. Pediatr Blood Cancer 2011. PubMed
  • Demarco TA, Nusbaum RH, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Tercyak KP. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together. Patient Educ Couns 2009; 78:29-33. PubMed
  • Peshkin BN, Demarco TA, Garber JE, Valdimarsdottir HB, Patenaude AF, Schneider KA, Schwartz MD, Tercyak KP. Brief Assessment of Parents' Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J Pediatr Psychol 2009; 34:627-38. PubMed
  • Patenaude AF,Orozco S,Li X,Kaelin CM,Gadd M,Matory Y,Mayzel K,Roche CA,Smith BL,Farkas W,Garber JE. Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology 2008; 17:831-43. PubMed
  • Demarco TA, Peshkin BN, Valdimarsdottir HB, Patenaude AF, Schneider KA, Tercyak KP. Role of Parenting Relationship Quality in Communicating about Maternal BRCA1/2 Genetic Test Results with Children. J Genet Couns 2008; 17:283-7. PubMed
  • Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test 2007; 11:249-55. PubMed
  • Patenaude AF, Julian-Reynier C. Special issue of Psycho-Oncology on cancer genetic testing and psychosocial research. Psychooncology 2007; 16:504. PubMed
  • Patenaude A, Deschesnes RG, Rousseau JL, Petitclerc E, Lacroix J, C. New soft alkylating agents with enhanced cytotoxicity against cancer cells resistant to chemotherapeutics and hypoxia. Cancer Res 2007; 67:2306-16. PubMed
  • Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF, Reynolds H, Dent K, Eubanks S, Goldman J, Leroy B, Warren NS, Taylor K, Vockley CW, Garber JE. Ethical issues in cancer genetics: I 1) whose information is it? J Genet Couns 2006; 15:491-503. PubMed
  • Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006; 24:700-6. PubMed
Hide